Herendeen Paul

SEC Form 4 insider trading activity

Herendeen Paul has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Aug 10, 2026.

On the most recent filing, Herendeen Paul is listed as Director at Elanco Animal Health Inc. Inside the rolling window, Herendeen Paul reported 1 open-market purchase totaling $237K in ELAN and no open-market sales.

Companies traded

Other insiders at ELAN

Insider Buying

$237K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
ELANPurchase$237KAug 10SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Herendeen Paul made?

Herendeen Paul has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.

Which companies does Herendeen Paul trade?

Herendeen Paul has filed SEC Form 4 disclosures for 1 company, including ELAN.

When was Herendeen Paul's most recent SEC Form 4 filing?

Herendeen Paul's most recent SEC Form 4 filing on Tracefour is dated Aug 10, 2026.

What is Herendeen Paul's total buy and sell value in the current window?

Inside the rolling retention window, Herendeen Paul bought $237K and sold $0 based on SEC Form 4 filings.

What was Herendeen Paul's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 10,000 ELAN shares on 2026-08-07, worth $237K, per SEC Form 4 filings.